5327372026-04-012026-06-305327372026-06-305327372026-04-012026-06-30in-capmkt:OtherRevenueFromOperations1Member5327372026-04-012026-06-30in-capmkt:OtherRevenueFromOperations2Member5327372026-04-012026-06-30in-capmkt:OtherExpenses1Member5327372026-04-012026-06-30ItemsThatWillNotBeReclassifiedToProfitAndLoss15327372026-04-012026-06-30AuditorDomain15327372026-06-30Statement15327372026-04-012026-06-30Statement15327372026-06-30Statement25327372026-04-012026-06-30Statement25327372026-06-30Statement35327372026-04-012026-06-30Statement35327372026-06-30Statement45327372026-04-012026-06-30Statement45327372026-06-30StatementDynamic1I1Statement15327372026-06-30StatementDynamic1I2Statement15327372026-06-30StatementDynamic2I1Statement25327372026-06-30StatementDynamic2I2Statement25327372026-06-30StatementDynamic3I1Statement35327372026-06-30StatementDynamic3I2Statement35327372026-06-30StatementDynamic4I1Statement45327372026-06-30StatementDynamic4I2Statement4iso4217:INRxbrli:pureiso4217:INRxbrli:shares532737EMKAYNOTLISTEDINE296H01011Emkay Global Financial Services LimitedMain BoardEquity2026-04-012027-03-312026-07-272026-07-22INRLakhsQuarterlyFirst quarterSingle segmentAdvisory amd Transactional Services2026-07-2716:00:002026-07-2717:30:00Declaration of unmodified opiniontrue4falseNot Applicable2026-04-012026-06-30UnauditedStandalone946820000067527000053810000000624100083000300044303000874306000000450230000556770002618500068170000000204204000804466000698400000698400004588000-1213000337500066465000000066465000271300069178000273301000102.482.24002.482.240.00480.01160.0124Reversal of impairment provisions on Financial instrument589000Other operating Income5652000Other expenses204204000Re-measurement gains/losses on defined benefit plans3626000362600091300002713000UnauditedtrueS. R. Batliboi & Co. LLPtrue2027-07-31Preferential Issues2026-04-30679520002026-06-30trueCARE Ratings LimitedfalseNANilNilSaket AgrawalChief Financial OfficerMumbai2026-07-27Preferential Issues2026-05-12745620002026-06-30trueCARE Ratings LimitedfalseNANilNilPreferential Issues2026-05-27179620002026-06-30trueCARE Ratings LimitedfalseNANilNilPreferential Issues2026-06-25179620002026-06-30trueCARE Ratings LimitedfalseNANilNilWorking Capital RequirementNo2025250000067952000075% of consideration was received against warrant issue price aggregated to Rs. 6,79,52,137.50/- (i.e. Rs. 179.625 per warrant) at the time of allotment of equity shares pursuant to conversion of warrants are fully utilized as per objects disclosed in offer document.General Corporate PurposeNo250000000000The general corporate purposes for which the Company proposed to utilize the proceeds of the Preferential Issue includes meeting day to day expenses which includes salaries and wages, administration, insurance, repairs and maintenance, payment of taxes and duties, servicing of borrowings including payment of interest, brand building and other marketing expenses, meeting expenses incurred in the ordinary course of business and towards any exigencies, and any other purpose as considered expedient and as approved periodically by Board or a duly constituted committee thereof, subject to compliance with applicable law, including the necessary provisions of the Companies Act, 2013.Working Capital RequirementNo2025250000074562000075% of consideration was received against warrant issue price aggregated to Rs. 7,45,62,337.50/- (i.e. Rs. 179.625 per warrant) at the time of allotment of equity shares pursuant to conversion of warrants are fully utilized as per objects disclosed in offer document.General Corporate PurposeNo250000000000The general corporate purposes for which the Company proposed to utilize the proceeds of the Preferential Issue includes meeting day to day expenses which includes salaries and wages, administration, insurance, repairs and maintenance, payment of taxes and duties, servicing of borrowings including payment of interest, brand building and other marketing expenses, meeting expenses incurred in the ordinary course of business and towards any exigencies, and any other purpose as considered expedient and as approved periodically by Board or a duly constituted committee thereof, subject to compliance with applicable law, including the necessary provisions of the Companies Act, 2013.Working Capital RequirementNo2025250000017962000075% of consideration was received against warrant issue price aggregated to Rs. Rs. 1,79,62,500.00/- (i.e. Rs. 179.625 per warrant) at the time of allotment of equity shares pursuant to conversion of warrants are fully utilized as per objects disclosed in offer document.General Corporate PurposeNo250000000000The general corporate purposes for which the Company proposed to utilize the proceeds of the Preferential Issue includes meeting day to day expenses which includes salaries and wages, administration, insurance, repairs and maintenance, payment of taxes and duties, servicing of borrowings including payment of interest, brand building and other marketing expenses, meeting expenses incurred in the ordinary course of business and towards any exigencies, and any other purpose as considered expedient and as approved periodically by Board or a duly constituted committee thereof, subject to compliance with applicable law, including the necessary provisions of the Companies Act, 2013.Working Capital RequirementNo2025250000017962000075% of consideration was received against warrant issue price aggregated to Rs. 1,79,62,500.00/- (i.e. Rs. 179.625 per warrant) at the time of allotment of equity shares pursuant to conversion of warrants are fully utilized as per objects disclosed in offer document.General Corporate PurposeNo250000000000The general corporate purposes for which the Company proposed to utilize the proceeds of the Preferential Issue includes meeting day to day expenses which includes salaries and wages, administration, insurance, repairs and maintenance, payment of taxes and duties, servicing of borrowings including payment of interest, brand building and other marketing expenses, meeting expenses incurred in the ordinary course of business and towards any exigencies, and any other purpose as considered expedient and as approved periodically by Board or a duly constituted committee thereof, subject to compliance with applicable law, including the necessary provisions of the Companies Act, 2013.